22/02/2018 10:54:53

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

Related content

FORM 8.5 EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Name of exempt principal trader:

HSBC BANK PLC

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

  Use a separate form for each offeror/offeree

 

Lonmin Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

 

Sibanye Gold Ltd

(d) Date dealing undertaken:

 

 21st February 2018

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

 

Yes

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

(GBP)

Lowest price per unit paid/received

(GBP)

Ordinary Shares Purchase 904  

75.230 p

 

75.230 p

Ordinary Shares Sale 904  

  75.230 p

 

  75.230 p

(b)        Derivatives transactions (other than options)

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit (GBP)

         

(c)        Options transactions in respect of existing securities

(i)         Writing, selling, purchasing or varying

Class of relevant security

Product description

e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

               

(ii)        Exercising

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

(d)        Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

3.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

Date of disclosure:

22nd February 2018

Contact name:

Sukant Roy

Telephone number:

0207 088 2000

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: HSBC Bank Plc via Globenewswire

Comments

#1 | Tuesday 6 Mar (00:47)
We specialize in financial instrument such as BGs/SBLCs/LCs/DLCs/BCLs/MTNs and others on lease and sales at a rate of (3 + 0.5 + X)% of the face value and reasonable conditions from a genuine & reliable provider, there are two types of bank guarantee which are Direct Bank Guarantee and Indirect Bank Guarantee. Our bank instruments can serves as collateral as the case may be, which will enable you get loans from your bank so as to embark on any projects such as Aviation, Agriculture, Petroleum, Mining, Telecommunication, Construction of Dams, Real estate, Bridges, Trading, Importing and exporting and Other Turnkey Project (s) etc. Intermediaries/Consultants/Brokers are welcome to bring their clients and are 100% protected. In complete confidence, we will work together for the benefits of all parties involved.If Interested kindly direct your enquiry to
Email:~ personal2617@protonmail.com
personal261712@outlook.com,
instrumentsmandate01@gmail.com serious enquiry only
Skype id: nathani.abhishek1

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Armanino Brings Unique Human Resources Solutions to the Accounting & Finance Show LA
2
ALSTOM SA: Alstom shareholders approve all submitted resolutions and the proposed combination of Alstom with Siemens' Mobility business
3
BJ’s Restaurants, Inc. Announces Date for Second Quarter 2018 Earnings Release and Conference Call
4
Mitel Optimizes Its Go-to-Market Strategy in EMEA & South Pacific; Signs Partnership With Westcon-Comstor
5
Crenezumab's Second Phase 3 Trial (CREAD 2) Fully Recruited - Updates on AC Immune's Pipeline and Technology Platforms to be presented at AAIC in Chicago

Related stock quotes

Buy and sell signals

  • Trend
  • Moneymachine

Latest news


Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 July 2018 06:05:11
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180712.1 - EUROWEB4 - 2018-07-18 07:05:11 - 2018-07-18 06:05:11 - 1000 - Website: OKAY